NovaGo Therapeutics
Business Services · Switzerland · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Wagistrasse 25-27, Schlieren, Zurich, 89...Website
www.novagotherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About NovaGo Therapeutics
NovaGo Therapeutics is a Swiss biotech company specializing in human antibody therapeutics aimed at promoting nerve growth and regeneration to improve recovery after spinal cord injuries. The company develops therapeutic antibodies that block the Nogo-A receptor, which inhibits nerve growth, and has demonstrated efficacy in preclinical models. NovaGo is preparing to initiate Phase 1b clinical trials for its treatments in 2024. Their primary clients include individuals affected by spinal cord injuries seeking enhanced functional recovery.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is NovaGo Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
NovaGo Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on NovaGo Therapeutics recently announced quarterly report
Funding: Get notified immidiatlly once NovaGo Therapeutics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if NovaGo Therapeutics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at NovaGo Therapeutics
Click to see if NovaGo Therapeutics had a recent Job posting/layoffs
Product Launch: Get notified when NovaGo Therapeutics launches new products
Check if NovaGo Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined NovaGo Therapeutics as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
NovaGo Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
NovaGo Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about NovaGo Therapeutics.
NovaGo Therapeutics Tech Stack
A closer look at the technologies used by NovaGo Therapeutics
See more technologies
NovaGo Therapeutics News & Media
NovaGo Therapeutics Raises CHF10M in Series A Financing
NovaGo Therapeutics AG, a Zurich, Switzerland-based biotech company developing human antibody therapeutics to promote regeneration after cerebral stroke, closed a Series A financing round of CHF 10m. The round was led by Pureos Bioventures and the strategic partner Neurimmune. In conjunction with the funding, Dr. Dominik Escher, Partner at Pureos Bioventures, will join NovaGo’s board […] The post NovaGo Therapeutics Raises CHF10M in Series A Financing appeared first on FinSMEs.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding NovaGo Therapeutics
Sign Up For FreeTo access detailed company insights
NovaGo Therapeutics is a Swiss biotech company specializing in human antibody therapeutics aimed at promoting nerve growth and regeneration to improve recovery after spinal cord injuries. The company develops therapeutic antibodies that block the Nogo-A receptor, which inhibits nerve growth, and has demonstrated efficacy in preclinical models. Nova... Read More
